Author:
Bhattacharya Reshmee,Saini Saakshi,Ghosh Souvik,Roy Partha,Ali Nemat,Parvez Mohammad Khalid,Al-Dosari Mohammed S.,Mishra Awdhesh Kumar,Singh Laishram Rajendrakumar
Abstract
AbstractDiabetes, characterized by high blood glucose level, is a progressive metabolic disease that leads to serious health complications. One of the major pathological consequences associated with diabetes is the accumulation of highly reactive carbonyl compounds called advanced glycation end products (AGEs). Most of the AGEs are dicarbonyls and have the potential to covalently modify proteins especially at the lysine residues in a non-enzymatic fashion (a process termed as glycation) resulting in the functional impairment and/or toxic gain in function. Therefore, non-toxic small molecules that can inhibit glycation are of interest for the therapeutic intervention of diabetes. In the present communication, we have investigated the effect of organosulfurs (S-allyl cysteine, SAC and N-acetyl cysteine, NAC) that are major principal components of Allium sativa against the glycation of different proteins. We discovered that both SAC and NAC are potent anti-glycating agents. We also found that both SAC and NAC reduce ROS level and inhibit apoptosis caused by protein glycation.
Funder
Researchers Supporting Project, King Saud University
Publisher
Springer Science and Business Media LLC